PubMed:10339482 / 0-182 JSONTXT

{"project":"jnlpba-st-training","denotations":[{"id":"T1","span":{"begin":0,"end":16},"obj":"protein"},{"id":"T2","span":{"begin":18,"end":23},"obj":"protein"},{"id":"T3","span":{"begin":26,"end":55},"obj":"protein"},{"id":"T4","span":{"begin":61,"end":66},"obj":"protein"},{"id":"T5","span":{"begin":84,"end":98},"obj":"protein"},{"id":"T6","span":{"begin":100,"end":103},"obj":"protein"},{"id":"T7","span":{"begin":108,"end":129},"obj":"cell_line"}],"text":"Protein kinase B (c-Akt), phosphatidylinositol 3-kinase, and STAT5 are activated by erythropoietin (EPO) in HCD57 erythroid cells but are constitutively active in an EPO-independent,"}

{"project":"genia-medco-coref","denotations":[{"id":"C1","span":{"begin":0,"end":24},"obj":"NP"},{"id":"C2","span":{"begin":108,"end":129},"obj":"NP"}],"text":"Protein kinase B (c-Akt), phosphatidylinositol 3-kinase, and STAT5 are activated by erythropoietin (EPO) in HCD57 erythroid cells but are constitutively active in an EPO-independent,"}

{"project":"GENIAcorpus","denotations":[{"id":"T1","span":{"begin":0,"end":16},"obj":"protein_molecule"},{"id":"T2","span":{"begin":18,"end":23},"obj":"protein_molecule"},{"id":"T3","span":{"begin":26,"end":55},"obj":"protein_molecule"},{"id":"T4","span":{"begin":61,"end":66},"obj":"protein_molecule"},{"id":"T5","span":{"begin":84,"end":98},"obj":"protein_family_or_group"},{"id":"T6","span":{"begin":100,"end":103},"obj":"protein_family_or_group"},{"id":"T7","span":{"begin":108,"end":129},"obj":"cell_line"},{"id":"T8","span":{"begin":166,"end":169},"obj":"protein_family_or_group"}],"text":"Protein kinase B (c-Akt), phosphatidylinositol 3-kinase, and STAT5 are activated by erythropoietin (EPO) in HCD57 erythroid cells but are constitutively active in an EPO-independent,"}